HIV treatment adherence, patient health literacy, and health care provider-patient communication: Results from the 2010 AIDS Treatment for Life International Survey

Journal of the International Association of Physicians in AIDS Care

Volumn 11, Issue 2, 2012, Pages 128-133

  Nachega, Jean B ^a,b   Morroni, Chelsea ^a   Zuniga, José M ^c   Schechter, Mauro ^d   Rockstroh, Jürgen ^e   Solomon, Suniti ^f   Sherer, Renslow ^g  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE   (United States)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e UNIVERSITY OF BONN   (Germany)

^f Center for AIDS Research and Education (YRG CARE)   (India)

^g UNIVERSITY OF CHICAGO   (United States)

Author keywords

adherence; antiretroviral therapy; communication; drug resistance; HIV; patient physician

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICA; ARTICLE; ASIA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DOCTOR PATIENT RELATION; FEMALE; HEALTH CARE PERSONNEL; HEALTH LITERACY; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RECALL; SELF REPORT; SOUTH AND CENTRAL AMERICA; STRUCTURED INTERVIEW;

ADOLESCENT; ADULT; AFRICA; ANTI-HIV AGENTS; AUSTRALIA; BRAZIL; COMMUNICATION; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DIRECTIVE COUNSELING; EUROPE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; PATIENT MEDICATION KNOWLEDGE; PHYSICIAN-PATIENT RELATIONS; REPUBLIC OF KOREA; UNITED STATES; YOUNG ADULT;

EID: 84859320513     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109712437244     Document Type: Article

References (44)

1. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21-30. (Pubitemid 30432540)
2. Bangsberg DR. Less than 95% adherence to non-nucleoside reverse transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43(7):939-941. (Pubitemid 44435526)
3. Maggiolo F, Ravasio L, Ripamonti D, et al. Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. Clin Infect Dis. 2005;40(1):158-163. (Pubitemid 40053474)
4. Nachega JB, Hislop M, Dowdy DW, et al. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med. 2007;146(8):564-573. (Pubitemid 351650537)
5. Shuter J, Sarlo JA, Kanmaz TJ, et al. HIV-infected patients receiving lopinavir/6. ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. J Acquir Immune Defic Syndr. 2007;45(7):4-8. (Pubitemid 46684437)
6. Martin M, Del Cacho E, Codina C, et al. Relationship between adherence 8. level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study. AIDS Res Hum Retroviruses. 2008;24(10):1263-1268.
7. Harrigan PR, Hogg RS, Dong WW, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005;191(3):339-347. (Pubitemid 40139758)
8. Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181-1183. (Pubitemid 32549871)
9. Hogg RS, Heath K, Bangsberg D, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002;16(7):1051-1058. (Pubitemid 34499429)
10. Wood E, Hogg RS, Yip B, et al. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl. AIDS. 2006;20(8):1117-1123. (Pubitemid 43786099)
11. Nachega JB, Hislop M, Dowdy DW, et al. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. 2006;43(1):78-84. (Pubitemid 44306492)
12. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010; 329(5996):1168-1174.
13. Grant RM, Lama JR, Anderson PL, et al. iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587-2599.
14. Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48-57.
15. Montaner JS, Lima VD, Barrios R, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2010;376(9740):532-539.
16. Stevens W, Kaye S, Corrah T. Antiretroviral therapy in Africa. BMJ. 2004;328(7434):280-282. (Pubitemid 38168143)
17. Hogg R, Cahn P, Katabira ET, et al. Time to act: global apathy towards HIV/AIDS is a crime against humanity. Lancet. 2002; 360(9347):1710-1711. (Pubitemid 35447895)
18. Nachega JB, Mills EJ, Schechter M. Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. Curr Opin HIV AIDS. 2010;5(1):70-77.
19. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient care committee & adherence working group of the outcomes committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255-266. (Pubitemid 30426745)
20. Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679-690. (Pubitemid 44200639)
21. Gill CJ, Hamer DH, Simon JL, et al. No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS. 2005;19(12):1243-1249. (Pubitemid 41224892)
22. Byakika-Tusiime J, Crane J, Oyugi JH, et al. Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS Behav. 2009;13(suppl 1):82-91.
23. Nachega JB, Chaisson RE, Goliath RE, et al. Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy in HIV-infected adults. AIDS. 2010;24(9):1273-1280.
24. Vance DE, Moneyham L, Fordham P, Struzick TC. model of suicidal ideation in adults aging with HIV. J Assoc Nurses AIDS Care. 2008;19(5):375-384.
25. Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438.
26. Kagee A, Remien RH, Berkman A, Hoffman S, Campos L, Swartz L. Structural barriers to ART adherence in Southern Africa: challenges and potential ways forward. Glob Public Health. 2010; 6(1):1-15.
27. Oyugi JH, Byakika-Tusiime J, Ragland K, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS. 2007;21(8):965-971. (Pubitemid 46684328)
28. Crane JT, Kawuma A, Oyugi JH, et al. The price of adherence: qualitative findings From HIV positive individuals purchasing fixed-dose combination generic HIV antiretroviral therapy in Kampala, Uganda. AIDS Behav. 2006;10(4):437-442. (Pubitemid 44174972)
29. Weiser S, Wolfe W, Bangsberg D, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003; 34(3):281-288. (Pubitemid 37377361)
30. Weiser SD, Tuller DM, Frongillo EA, Senkungu J, Mukiibi N, Bangsberg DR. Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS One. 2010;5(4):e10340.
31. Kagee A, Delport T. Barriers to adherence to antiretroviral treatment. The perspectives of patient advocates. J Health Psychol. 2010;15(7):1001-1011.
32. Rao D, Kekwaletswe TC, Hosek S, et al. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care. 2007;19(1):28-33. (Pubitemid 44852407)
33. Ware NC, Wyatt MA, Tugenberg T. Social relationships, stigma, and adherence to antiretroviral therapy for HIV/AIDS. AIDS Care. 2006;18(8):904-910. (Pubitemid 44521844)
34. Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDs. 2006;20(5):359-368. (Pubitemid 43800964)
35. Sayles JN, Wong MD, Cunningham WE. The inability to take medications openly at home: does it explain gender disparities in HAART use? J Womens Health (Larchmt). 2006;15(2): 173-181.
36. Nachega JB, Stein DM, Lehman DA, et al. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses. 2004;20(10):1053-1056. (Pubitemid 39392009)
37. Bezreh T, LawsMB, Taubin T, RifkinDE, Wilson IB. Challenges to physician-patient communication about medication use: a window into the skeptical patient's world. Patient Prefer Adherence. 2011; 2012(6):11-18. http://dx.doi.org/10.2147/PPA.S25971. Accessed January 7, 2011.
38. Racey CS, Zhang W, Brandson EK, et al. HIV antiretroviral drug resistance: patient comprehension. AIDS Care. 2010;22(7): 816-826.
39. Kumarasamy N, Safren SA, Raminani SR, et al. Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study. AIDS Patient Care STDs. 2005;19(8):526-537. (Pubitemid 41262633)
40. Heijnders M, Van Der Meij S. The fight against stigma: an overview of stigma reduction strategies and interventions. Psychol Health Med. 2006;11(3):353-363.
41. Brown L, Macintyre K, Trujillo L. Interventions to reduce HIV/ AIDS stigma: what have we learned? AIDS Educ Prevent. 2003;15(1):49-69. (Pubitemid 36237152)
42. Ehiri JE, Anyanwu EC, Donath E, et al. AIDS related stigma in Sub-Saharan Africa: its contexts and potential intervention strategies. AIDS Public Policy J. 2005;20(1-2):25-39. (Pubitemid 44464819)
43. Kuhn L, Steinberg M, Mathews C. Participation of the school community in AIDS education: an evaluation of a high school program in South Africa. AIDS Care. 1994;6(2):161-171. (Pubitemid 24151502)
44. Simoni JM, Kurth AE, Pearson CR, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006; 10(3):227-245.